معلومات الدخول المتعلقة بالاتفاقات البيئية المتعددة الأطراف

Related strategic items

• Operational Objective 1.1 National Biosafety Frameworks. To enable all Parties to have operational national biosafety frameworks in place for the implementation of the Protocol

  SDG Goals:

  Goal 3 Goal 12 Goal 14 Goal 15 Goal 16 Goal 17 Target 3.d Target 12.2 Target 14.2 Target 15.5 Target 15.9 Target 16.3 Target 16.6 Target 17.15

  • Indicator 1.1.1 Number of Parties, in particular centers of origin, that have in place national biosafety legislation and implementing guidelines not more than 6 years after accession to/ratification of the Protocol

  • Indicator 1.1.2 Percentage of the Parties that have in place administrative rules and procedures for handling notifications and requests for approval of imports of LMOs intended for direct use as food or feed, or for processing; contained use and for introduction into the environment

  • Indicator 1.1.3 Percentage of Parties that have designated national focal points and competent national authorities

  • Indicator 1.1.4 Percentage of Parties that have received notifications in accordance with Article 8 of the Protocol or appropriate domestic legislation.

  • Indicator 1.1.5 Percentage of Parties that have taken import decisions in accordance with Article 10 of the Protocol or appropriate domestic legislation.

• Operational Objective 1.2 Coordination and support. To put in place effective mechanisms for developing biosafety systems with the necessary coordination, financing and monitoring support

  SDG Goals:

  Goal 3 Goal 12 Goal 15 Goal 16 Goal 17 Target 3.d Target 12.2 Target 15.a Target 16.3 Target 16.6 Target 17.15

  • Indicator 1.2.1 Number of Parties that have assessed their capacity-building needs, including training and institutional needs, and submitted the information to the BCH not more than 3 years after accession to/ratification of the Protocol

  • Indicator 1.2.2 Percentage of the Parties that have developed national biosafety capacity-building action plans for implementing the Protocol

  • Indicator 1.2.3 Percentage of the Parties that have in place training programmes for personnel dealing with biosafety issues and for long-term training of biosafety professionals

  • Indicator 1.2.4 Percentage of Parties that have in place national coordination mechanisms for biosafety capacity-building initiatives

  • Indicator 1.2.5 Amount of new and additional financial resources mobilized for the implementation of the Protocol

  • Indicator 1.2.6 Number of Parties that have predictable and reliable funding for strengthening their capacity in implementing the Protocol

  • Indicator 1.2.7 Number of Parties reporting that their capacity-building needs have been met

  • Indicator 1.2.8 Number of cooperative arrangements reported involving LMO exporting and importing Parties

• Operational Objective 1.3 Risk assessment and risk management. To further develop and support implementation of scientific tools on common approaches to risk assessment and risk management for Parties

  SDG Goals:

  Goal 3 Goal 12 Goal 14 Goal 15 Target 3.d Target 12.8 Target 14.a Target 14.2 Target 15.5 Target 15.9

  • Indicator 1.3.1 Percentage of Parties adopting and using guidance documents on risk assessment and risk management for the purpose of: 1. Performing their own risk assessment and risk management; 2. Evaluating risk assessment reports submitted by notifiers.

  • Indicator 1.3.2 Percentage of Parties adopting common approaches to risk assessment and risk management

  • Indicator 1.3.3 Percentage of Parties that undertake actual risk assessment pursuant to the Protocol.

• Operational Objective 1.4 LMOs or traits that may have adverse effects. To develop modalities for cooperation and guidance in identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health

  SDG Goals:

  Goal 3 Goal 12 Goal 14 Goal 15 Goal 16 Goal 17 Target 3.d Target 12.2 Target 12.8 Target 14.2 Target 15.5 Target 15.9 Target 16.6 Target 17.6 Target 17.14 Target 17.16

  • Indicator 1.4.1 Guidance on living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health, developed by Parties and available

  • Indicator 1.4.2 Number of Parties that have the capacity to identify, assess and monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health.

• Operational Objective 1.5 Liability and Redress. To adopt and implement the Nagoya – Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety.

  SDG Goals:

  Goal 3 Goal 14 Goal 15 Goal 16 Goal 17 Target 3.d Target 14.2 Target 15.5 Target 16.3 Target 16.6 Target 17.13

  • Indicator 1.5.1 Entry into force of the Nagoya – Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety prior to the seventh meeting of the Conference of the Parties serving as the meeting of the Parties to the Protocol

  • Indicator 1.5.2 Percentage of Parties to the Nagoya – Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety having in place national administrative and legal frameworks incorporating rules and procedures on liability and redress for damage caused by living modified organisms

• Operational Objective 1.6 Handling, transport, packaging and identification. To enable Parties to implement the requirements of the Protocol and COP-MOP decisions on identification and documentation requirements for living modified organisms

  SDG Goals:

  Goal 16 Goal 17 Target 16.3 Target 16.6 Target 17.14 Target 17.16

  • Indicator 1.6.1 Percentage of Parties that put in place documentation requirements for living modified organisms intended for direct use as food or feed, or for processing

  • Indicator 1.6.2 Percentage of Parties that put in place documentation requirements for living modified organisms for contained use and for intentional introduction into the environment

  • Indicator 1.6.3 Number of Parties with access to tools that are capable of detecting unauthorized LMOs.

  • Indicator 1.6.4 Number of Parties using guidance developed for the handling, transport and packaging of LMOs

• Operational Objective 1.7 Socio-economic considerations. To, on the basis of research and information exchange, provide relevant guidance on socio-economic considerations that may be taken into account in reaching decisions on the import of living modified organisms

  SDG Goals:

  Goal 3 Goal 10 Goal 16 Goal 17 Target 3.d Target 10.2 Target 10.3 Target 16.3 Target 16.6 Target 16.b Target 17.14 Target 17.16 Target 17.18

  • Indicator 1.7.1 Number of peer reviewed research papers published, made available and used by Parties in considering socio-economic impacts of LMOs

  • Indicator 1.7.2 Number of Parties reporting on their approaches to taking socioeconomic considerations into account

  • Indicator 1.7.3 Number of Parties reporting on their experiences in taking socio-economic considerations into account in reaching decisions on import of living modified organisms

  • Indicator 1.7.4 Number of Parties using guidelines on socio-economic considerations

• Operational Objective 1.8 Transit, contained use, unintentional transboundary movements and emergency measures. To develop tools and guidance that facilitate the implementation of the Protocol's provisions on transit, contained use, unintentional transboundary movements and emergency measures

  SDG Goals:

  Goal 3 Goal 16 Goal 17 Target 3.d Target 16.3 Target 16.6 Target 17.14 Target 17.16 Target 17.18

  • Indicator 1.8.1 Percentage of Parties having in place measures to manage LMOs in transit

  • Indicator 1.8.2 Percentage of Parties having in place measures for contained use

  • Indicator 1.8.3 Percentage of Parties using the guidance to detect occurrence of unintentional releases of living modified organisms and being able to take appropriate response measures